Company profile

Nurix Therapeutics, Inc. insider acquisitions

Company CIK 0001549595 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
NRIX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
90-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Exercise / conversionCode MCommon StockNon-derivative · Currency not specified3Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Hansen GwennHansen GwennGREGORY JULIA PGREGORY JULIA PRing ChristineRing ChristineDANSEY ROGER DDANSEY ROGER Dvan Houte Hansvan Houte HansHansen Gwenn · October 15, 2026 · Exercise / conversion · Common StockGREGORY JULIA P · October 14, 2026 · Exercise / conversion · Common StockRing Christine · October 2, 2026 · Exercise / conversion · Common StockRing Christine · December 18, 2025 · Exercise / conversion · Common StockRing Christine · November 24, 2025 · Exercise / conversion · Common StockDANSEY ROGER D · November 6, 2025 · Stock award · Director Stock Option (right to buy)van Houte Hans · October 30, 2025 · Exercise / conversion · Common Stockvan Houte Hans · October 30, 2025 · Exercise / conversion · Common Stockvan Houte Hans · October 30, 2025 · Exercise / conversion · Common Stockvan Houte Hans · October 30, 2025 · Exercise / conversion · Common StockRing Christine · October 30, 2025 · Exercise / conversion · Common StockRing Christine · October 30, 2025 · Exercise / conversion · Common StockRing Christine · October 30, 2025 · Exercise / conversion · Common StockRing Christine · October 30, 2025 · Exercise / conversion · Common StockHansen Gwenn · October 30, 2025 · Exercise / conversion · Common StockHansen Gwenn · October 30, 2025 · Exercise / conversion · Common StockHansen Gwenn · October 30, 2025 · Exercise / conversion · Common StockHansen Gwenn · October 30, 2025 · Exercise / conversion · Common StockHansen Gwenn · October 14, 2025 · Stock award · Restricted Stock UnitsOct 14, 2025Oct 15, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

19 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 15, 2026Nurix Therapeutics, Inc.Common StockHansen GwennExercise / conversion
Oct 14, 2026Nurix Therapeutics, Inc.Common StockGREGORY JULIA PExercise / conversion
Oct 2, 2026Nurix Therapeutics, Inc.Common StockRing ChristineExercise / conversion
Dec 18, 2025Nurix Therapeutics, Inc.Common StockRing ChristineExercise / conversion
Nov 24, 2025Nurix Therapeutics, Inc.Common StockRing ChristineExercise / conversion
Nov 6, 2025Nurix Therapeutics, Inc.Director Stock Option (right to buy)DANSEY ROGER DStock award
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte HansExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte HansExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte HansExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte HansExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing ChristineExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing ChristineExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing ChristineExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing ChristineExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen GwennExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen GwennExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen GwennExercise / conversion
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen GwennExercise / conversion
Oct 14, 2025Nurix Therapeutics, Inc.Restricted Stock UnitsHansen GwennStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

NRIX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,4521.86Value: 2,700.72Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M22,5831.86Value: 42,004.38Currency not specifiedView ↗
Trade:
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M5,7868.72Value: 50,453.92Currency not specifiedView ↗
Trade:
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,7601.86Value: 6,993.6Currency not specifiedView ↗
Trade:
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M37,6001.86Value: 69,936Currency not specifiedView ↗
Trade: Stock awardDirector Stock Option (right to buy)Derivative security · Code A50,0000Value: 0Currency not specifiedView ↗
Trade:
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8580Value: 0Currency not specifiedView ↗
Trade:
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,7500Value: 0Currency not specifiedView ↗
Trade:
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,0000Value: 0Currency not specifiedView ↗
Trade:
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8860Value: 0Currency not specifiedView ↗
Trade:
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8580Value: 0Currency not specifiedView ↗
Trade:
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,7500Value: 0Currency not specifiedView ↗
Trade:
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,0000Value: 0Currency not specifiedView ↗
Trade:
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,9240Value: 0Currency not specifiedView ↗
Trade:
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8580Value: 0Currency not specifiedView ↗
Trade:
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,7500Value: 0Currency not specifiedView ↗
Trade:
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,0000Value: 0Currency not specifiedView ↗
Trade:
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,2070Value: 0Currency not specifiedView ↗
Trade:
Hansen GwennChief Scientific Officer
Stock awardRestricted Stock UnitsDerivative security · Code A20,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →